We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Peginterferon beta 1a (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Peginterferon beta 1a (rch) [PDF, 1.2 MB]

AusPAR: Peginterferon beta 1a (rch) [Word, 2.02 MB]

Attachment: Product Information: Peginterferon beta 1a (rch) [PDF, 270.42 KB]

Attachment: Product Information: Peginterferon beta 1a (rch) [Word, 65 KB]

Attachment: Extract from the Clinical Evaluation Report: Peginterferon beta 1a (rch) [PDF, 3.72 MB]

Attachment: Extract from the Clinical Evaluation Report: Peginterferon beta 1a (rch) [Word, 10.64 MB]

Device/Product Name

Plegridy

Active ingredients

Peginterferon beta 1a (rch)

AusPAR Date

5 February 2015

Published

20 March 2015

Submission Number

PM-2013-02425-1-1

Submission Type

Biological medicine

Decision

Approved